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Identity 
Other names: FLJ10169 
HGNC (Hugo): TBX2 
Location: 17q23 
Local order: Genes flanking TBX2 in centromere to 
telomere direction on 17q23 are:  
APPBP2, 17q21-q23, amyloid beta precursor protein 
(cytoplasmic tail) binding protein 2. 
TBX2, 17q23, T-box2. 
PPM1D, 17q23, protein phosphatase 1D magnesium-
dependent, delta isoform. 
LOC440450, 17q23.2 LOC440450. 
LOC388407, 17q23.2, hypothetical gene supported by 
BC046200. 
LOC388406, 17q23.2, hypothetical LOC388406. 
MGC71999, 17q23.2, alpha-NAC protein. 
Note: T-box proteins contain a T-domain that has roles 
in dimerization and DNA binding. TBX2 belongs to the 
Tbx2 subfamily of T-box transcription factors. Other 
subfamilies of T-box genes are Brachyury, T-brain1, 
Tbx1 and Tbx6.  
TBX2, TBX3, TBX4 and TBX5 belong to the Tbx2 
subfamily. TBX2 and TBX3 are the only mammalian 




Genes of the same T-box subfamily are thought to have 
arisen from duplication and recombination of a single 
ancestor gene. TBX2 is most closely related to TBX3 
(12q24), whereas the other members of the subfamily, 
TBX4 and TBX5, are more closely related to one 
another. It is postulated that genes of the same 
subfamily may have redundant expression patterns and 
thus potential functional redundancy. 
Description 
TBX2 gene spans 9,5kb. TBX2 gene has 7 exons and 
the sizes of the exons 1 to 7 are 676, 268, 147, 77, 164, 
635, 1413 bps. Exon/intron boundaries of TBX2 and a 
polymorphism within intron 2 of the gene have also 
been reported. 
 
















TBX2 mRNA is 3396 bp. TBX2 mRNA is expressed in 
a wide variety of tissues including fetal kidney and 
fetal lung as well as multiple adult tissues, kidney, 
lung, placenta, ovary, prostate, spleen, testis and breast. 
Relatively reduced expression of TBX2 can be detected 
in heart, white blood cells, small intestine and thymus. 
Transcript size heterogeneity has been detected for 
TBX2, possibly due to alternative polyadenylation. 
Increased TBX2 mRNA is observed within 2 hours 
after addition of retinoic acid in B16 mouse melanoma 
cells due to the presence of a degenerate retinoic acid 
response element (RARE) between -186 and -163 in 
the promoter region of the TBX2 gene. 
Transcript localisation: Human and mouse TBX2, 
TBX3, and TBX5 transcripts detected by riboprobes 
are found asymmetrically across the embryonic neural 
retina, with highest levels of transcripts within dorsal 
and peripheral retina. The dorsoventral gradient of 
TBX2 expression cannot be detected before the 
ganglion cell layer (GCL) forms and expression is 
found to be restricted to the inner neuroblastic retina 
and later to the GCL and inner nuclear layer. TBX2 
transcript is also detected in the optic and otic vesicles 
at 9.5 dpc, and in the naso-facial mesenchyme, and 
later in the developing limbs and other internal organ 
primordia (of lungs and genitalia). Later at around 8 
and 10 dpc, TBX2 is detected in allantois, inflow tract 
(IFT), outflow tract (OFT) and atrio-ventricular canal 
(AVC) of the developing mouse heart. Chick heart 
development is also consistent in terms of similar 
TBX2 expression patterns. During mammary 
development, TBX2 expression is detected at 11.5 dpc 
in the mesodermal milk lines. 
Pseudogene 
No pseudogenes have been reported for TBX2. 
Protein 
Description 
Protein consists of 702 amino acids and is 74.2 kDa. 
Protein has the T-box DNA binding domain 
(corresponds to amino acids 96-279) of the T-box 
family of transcriptional regulators. 
Function 
In an evolutionarily diverse group of organisms 
including chick, Xenopus, mouse, and human, TBX2 is 
involved during development of widely diverse organs 
and tissues including limbs, kidneys, lungs, mammary 
glands, heart and craniofacial structures. 
In order to identify genes that may be regulated by 
Tbx2, mouse cDNA microarrays were used to analyze 
differential gene expression profiles, comparing stably 
transfected NIH3T3 cells  
overexpressing Tbx2 with vector-transfected controls.  
107 genes were up-regulated (more than or equal to 2-
fold) and 66 genes were down-regulated (more than or 
equal to 2-fold). Among the upregulated genes in the 
Tbx2-overexpressing cells were: Caveolin, 
Pleiotrophin, Osteoblast-specific factor-2 and Collagen 
Type I alpha. Cadherin 3, Tenascin C, and Insulin-like 
Growth Factor Binding Protein 10/CYR61 (IBP10) 
were among the genes that are downregulated. In vitro 
reporter assays and transgenic mice studies suggest that 
TBX2 represses the transcription of certain cardiac 
genes (e.g. Connexin 40, Connexin 43, and Natriuretic 
Peptide Precursor A) during heart development. TBX2 
and TBX3 are also thought to be regulating one another 
in Hedgehog related signaling pathways during chick 
limb development.  
In addition to developmental functions, evidence 
suggest that TBX2 also has important roles in cell cycle 
regulation through repressing the expression of 
CDKN1A (p21, cyclin-dependent kinase inhibitor) and 
CDKN2A (p19ARF). In BMI oncogene deficient 
murine embryonic fibroblasts, TBX2 is shown to 
repress the CDKN2A promoter and also attenuate the 
induction of CDKN2A by E2F1, MYC, and HRAS, 
providing senescence bypass and suggesting TBX2 as a 
potent immortalizing gene. 
Homology 
C.familiaris: Tbx2, T-box 2 transcription factor. 
M.musculus: Tbx2, T-box 2. 
R.norvegicus: Tbx2_predicted, T-box 2 (predicted) 
D.melanogaster: bi, bifid. 
A.gambiae: 1280927, Anopheles gambiae str. PEST 
ENSANGG00000011542 gene. 
C.elegans: tbx-2, T-box family member (47.0 kD). 
Mutations 
Germinal 
Despite the high frequency T-box family gene 
mutations identified as causes of congenital 
developmental disorders, there have been no mutations 
reported for TBX2 that cause congenital anomalies. 
Germline segregation of TBX2 mutations with human 
diseases has not been identified. 
Somatic 
CGH (comparative genomic hybridization), Southern 
blot, FISH, PCR based techniques and microarray 
analyses suggest amplification and overexpression of 




TBX2 has been found to be amplified and 
overexpressed in breast cancer cell lines and primary 
tumors. TBX2 resides on the chromosomal band 17q23 
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that is frequently amplified in breast cancer cells. 
Evidence suggests presence of distinct proximal and 
distal amplicons on 17q23 with defined boundaries. 
TBX2 seems to be at the center of the distal amplicon. 
In addition to breast cancer cell line data, a study of 
tissue microarray of 372 primary tumors found TBX2 
amplification in 8.6% of the cases. Moreover, 
preferential amplification and overexpression of TBX2 
have been detected in BRCA1 and BRCA2 mutated 
breast tumors compared to sporadic controls. 
Pancreatic Cancer 
Note 
TBX2 amplification has been detected in 50% of 20 




TBX2 overexpression in melanoma cell lines is thought 
to target histone deacetylase 1 to the CDKN1A 
initiator. Expression of a dominant-negative Tbx2 leads 
to displacement of histone deacetylase 1 with up-
regulation of CDKN1A expression and the induction of 
replicative senescence in CDKN2A-null B16 
melanoma cells. In human melanoma cells, expression 
of the same dominant negative TBX2 results with 
reduced growth and induction of senescence-associated 
heterochromatin foci. 
Note 
Analysis of TBX2 in other tumor types has not been 
widely reported. 
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